Elliot Marseille, DrPH, MPP
University of California San Francisco & University of California Berkeley
Dr. Elliot Marseille, DrPH, MPP is the Founding Director of UC Berkeley’s Collaborative for the Economics of Psychedelics (CEP), and Principal of the firm Health Strategies International. He has 35 years of senior public health management and research experience and has published widely on the economics of global health interventions. He is the Co-Director of the Cost-Effectiveness Analysis in Medicine and Public Health course at UCSF.
Dr. Marseille is a leading expert on the economics of the emerging psychedelic-assisted therapies. He consulted with the Multidisciplinary Association for Psychedelic Studies (MAPS) on the economics of MDMA-assisted psychotherapy for the treatment of PTSD. Among other projects, he and the larger CEP team consult with the Usona Institute on the cost-effectiveness of psilocybin-assisted therapy to treat major depression; and with John Hopkins University on the cost-effectiveness of psilocybin-assisted therapy for tobacco cessation. CEP aims to make these and other analytic tools available as a public good to qualified researchers. Dr. Marseille’s additional interests include exploring the ethical foundations of cost-effectiveness analysis and identifying sound criteria for judging cost-effectiveness.